[Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
D000527:Alprostadil / Q000031:analogs & derivatives / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects; D016595:Misoprostol; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000517:prevention & control; D013392:Sucralfate / Q000627:therapeutic use
D000863:Antacids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006635:Histamine H2 Antagonists; D016595:Misoprostol; D013392:Sucralfate; D000527:Alprostadil
Antirheumatika-bedingte Schädigungen der Gastroduodenal-Schleimhaut: Ansätze zur Reduktion.